A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Zomedica Corp. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 45,280 shares of ZOM stock, worth $5,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,280
Previous 45,280 -0.0%
Holding current value
$5,433
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$0.12 - $0.18 $120 - $180
1,000 Added 2.26%
45,280 $7,000
Q1 2024

Apr 24, 2024

SELL
$0.12 - $0.19 $9,360 - $14,820
-78,000 Reduced 63.79%
44,280 $6,000
Q4 2023

Feb 09, 2024

SELL
$0.15 - $0.22 $1,020 - $1,496
-6,800 Reduced 5.27%
122,280 $24,000
Q3 2023

Oct 24, 2023

SELL
$0.16 - $0.23 $1.78 Million - $2.56 Million
-11,128,480 Reduced 98.85%
129,080 $22,000
Q2 2023

Jul 13, 2023

BUY
$0.19 - $0.22 $190 - $220
1,000 Added 0.01%
11,257,560 $2.25 Million
Q1 2023

May 11, 2023

BUY
$0.16 - $0.29 $10,304 - $18,676
64,400 Added 0.58%
11,256,560 $2.38 Million
Q3 2022

Oct 17, 2022

BUY
$0.2 - $0.38 $4,000 - $7,600
20,000 Added 0.18%
11,192,160 $0
Q2 2022

Jul 13, 2022

BUY
$0.2 - $0.34 $1,200 - $2,040
6,000 Added 0.05%
11,172,160 $2.46 Million
Q1 2022

May 12, 2022

BUY
$0.28 - $0.4 $6,580 - $9,400
23,500 Added 0.21%
11,166,160 $3.8 Million
Q4 2021

Feb 03, 2022

BUY
$0.31 - $0.58 $261 - $490
845 Added 0.01%
11,142,660 $3.45 Million
Q3 2021

Nov 02, 2021

SELL
$0.46 - $0.81 $677 - $1,193
-1,473 Reduced 0.01%
11,141,815 $5.79 Million
Q2 2021

Aug 10, 2021

SELL
$0.72 - $1.46 $799,905 - $1.62 Million
-1,110,980 Reduced 9.07%
11,143,288 $9.25 Million
Q1 2021

May 07, 2021

BUY
$0.35 - $2.7 $65 - $507
188 Added 0.0%
12,254,268 $19.4 Million
Q4 2020

Feb 04, 2021

BUY
$0.07 - $0.25 $857,785 - $3.06 Million
12,254,080 New
12,254,080 $2.82 Million

Others Institutions Holding ZOM

About Zomedica Corp.


  • Ticker ZOM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 979,950,016
  • Market Cap $118M
  • Description
  • Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...
More about ZOM
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.